Logo image of LXS.DE

LANXESS AG (LXS.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:LXS - DE0005470405 - Common Stock

17.62 EUR
0 (0%)
Last: 12/30/2025, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to LXS. LXS was compared to 68 industry peers in the Chemicals industry. The financial health of LXS is average, but there are quite some concerns on its profitability. LXS is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year LXS was profitable.
In the past year LXS had a positive cash flow from operations.
Of the past 5 years LXS 4 years were profitable.
Each year in the past 5 years LXS had a positive operating cash flow.
LXS.DE Yearly Net Income VS EBIT VS OCF VS FCFLXS.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

1.2 Ratios

LXS's Return On Assets of -2.97% is on the low side compared to the rest of the industry. LXS is outperformed by 75.00% of its industry peers.
Looking at the Return On Equity, with a value of -6.23%, LXS is doing worse than 75.00% of the companies in the same industry.
Industry RankSector Rank
ROA -2.97%
ROE -6.23%
ROIC N/A
ROA(3y)1.66%
ROA(5y)3.5%
ROE(3y)3.89%
ROE(5y)9.65%
ROIC(3y)N/A
ROIC(5y)N/A
LXS.DE Yearly ROA, ROE, ROICLXS.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

LXS's Operating Margin has declined in the last couple of years.
LXS's Gross Margin of 20.52% is on the low side compared to the rest of the industry. LXS is outperformed by 73.53% of its industry peers.
In the last couple of years the Gross Margin of LXS has declined.
The Profit Margin and Operating Margin are not available for LXS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 20.52%
OM growth 3Y-49.18%
OM growth 5Y-37.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.56%
GM growth 5Y-4.64%
LXS.DE Yearly Profit, Operating, Gross MarginsLXS.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20 25

4

2. Health

2.1 Basic Checks

LXS does not have a ROIC to compare to the WACC, probably because it is not profitable.
LXS has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, LXS has more shares outstanding
Compared to 1 year ago, LXS has an improved debt to assets ratio.
LXS.DE Yearly Shares OutstandingLXS.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
LXS.DE Yearly Total Debt VS Total AssetsLXS.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

An Altman-Z score of 1.89 indicates that LXS is not a great score, but indicates only limited risk for bankruptcy at the moment.
LXS has a worse Altman-Z score (1.89) than 69.12% of its industry peers.
The Debt to FCF ratio of LXS is 22.13, which is on the high side as it means it would take LXS, 22.13 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of LXS (22.13) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.62 indicates that LXS is somewhat dependend on debt financing.
The Debt to Equity ratio of LXS (0.62) is worse than 64.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 22.13
Altman-Z 1.89
ROIC/WACCN/A
WACC4.4%
LXS.DE Yearly LT Debt VS Equity VS FCFLXS.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

2.3 Liquidity

LXS has a Current Ratio of 2.60. This indicates that LXS is financially healthy and has no problem in meeting its short term obligations.
LXS has a better Current ratio (2.60) than 77.94% of its industry peers.
LXS has a Quick Ratio of 1.29. This is a normal value and indicates that LXS is financially healthy and should not expect problems in meeting its short term obligations.
LXS has a better Quick ratio (1.29) than 63.24% of its industry peers.
Industry RankSector Rank
Current Ratio 2.6
Quick Ratio 1.29
LXS.DE Yearly Current Assets VS Current LiabilitesLXS.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2

3. Growth

3.1 Past

LXS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -10.28%.
Measured over the past years, LXS shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -19.38% on average per year.
LXS shows a decrease in Revenue. In the last year, the revenue decreased by -6.82%.
LXS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.32% yearly.
EPS 1Y (TTM)-10.28%
EPS 3Y-31.1%
EPS 5Y-19.38%
EPS Q2Q%-108.14%
Revenue 1Y (TTM)-6.82%
Revenue growth 3Y1.43%
Revenue growth 5Y-1.32%
Sales Q2Q%-16.27%

3.2 Future

LXS is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.37% yearly.
The Revenue is expected to decrease by -0.30% on average over the next years.
EPS Next Y-76.8%
EPS Next 2Y-32.14%
EPS Next 3Y-2.73%
EPS Next 5Y6.37%
Revenue Next Year-9.82%
Revenue Next 2Y-5.41%
Revenue Next 3Y-2.72%
Revenue Next 5Y-0.3%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
LXS.DE Yearly Revenue VS EstimatesLXS.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B 8B
LXS.DE Yearly EPS VS EstimatesLXS.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 2 4

4

4. Valuation

4.1 Price/Earnings Ratio

LXS is valuated rather expensively with a Price/Earnings ratio of 18.35.
Based on the Price/Earnings ratio, LXS is valued a bit cheaper than the industry average as 67.65% of the companies are valued more expensively.
LXS's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.51.
The Price/Forward Earnings ratio is 24.22, which indicates a rather expensive current valuation of LXS.
Compared to the rest of the industry, the Price/Forward Earnings ratio of LXS indicates a slightly more expensive valuation: LXS is more expensive than 61.76% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.13, LXS is valued at the same level.
Industry RankSector Rank
PE 18.35
Fwd PE 24.22
LXS.DE Price Earnings VS Forward Price EarningsLXS.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, LXS is valued cheaper than 80.88% of the companies in the same industry.
86.76% of the companies in the same industry are more expensive than LXS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 13.58
EV/EBITDA 6.02
LXS.DE Per share dataLXS.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

LXS's earnings are expected to decrease with -2.73% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-32.14%
EPS Next 3Y-2.73%

0

5. Dividend

5.1 Amount

LXS has a yearly dividend return of 0.59%, which is pretty low.
LXS's Dividend Yield is slightly below the industry average, which is at 2.51.
Compared to an average S&P500 Dividend Yield of 2.00, LXS's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.59%

5.2 History

The dividend of LXS decreases each year by -35.08%.
Dividend Growth(5Y)-35.08%
Div Incr Years0
Div Non Decr Years1
LXS.DE Yearly Dividends per shareLXS.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

The earnings of LXS are negative and hence is the payout ratio. LXS will probably not be able to sustain this dividend level.
DP-4.12%
EPS Next 2Y-32.14%
EPS Next 3Y-2.73%
LXS.DE Yearly Income VS Free CF VS DividendLXS.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

LANXESS AG

FRA:LXS (12/30/2025, 7:00:00 PM)

17.62

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-06 2025-11-06/bmo
Earnings (Next)03-19 2026-03-19/amc
Inst Owners73.07%
Inst Owner ChangeN/A
Ins Owners2.86%
Ins Owner ChangeN/A
Market Cap1.52B
Revenue(TTM)5.89B
Net Income(TTM)-243.00M
Analysts56.3
Price Target19.56 (11.01%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.59%
Yearly Dividend0.1
Dividend Growth(5Y)-35.08%
DP-4.12%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)292.85%
Min EPS beat(2)79.47%
Max EPS beat(2)506.23%
EPS beat(4)4
Avg EPS beat(4)279.29%
Min EPS beat(4)79.47%
Max EPS beat(4)506.23%
EPS beat(8)8
Avg EPS beat(8)234.01%
EPS beat(12)11
Avg EPS beat(12)164.45%
EPS beat(16)14
Avg EPS beat(16)126.78%
Revenue beat(2)0
Avg Revenue beat(2)-8.07%
Min Revenue beat(2)-8.49%
Max Revenue beat(2)-7.66%
Revenue beat(4)0
Avg Revenue beat(4)-5.7%
Min Revenue beat(4)-8.49%
Max Revenue beat(4)-1.78%
Revenue beat(8)1
Avg Revenue beat(8)-4.92%
Revenue beat(12)2
Avg Revenue beat(12)-4.05%
Revenue beat(16)3
Avg Revenue beat(16)-5.05%
PT rev (1m)-10.67%
PT rev (3m)-28.5%
EPS NQ rev (1m)20.2%
EPS NQ rev (3m)19.67%
EPS NY rev (1m)-23.15%
EPS NY rev (3m)125.93%
Revenue NQ rev (1m)-0.3%
Revenue NQ rev (3m)-5.16%
Revenue NY rev (1m)-1.78%
Revenue NY rev (3m)-3.34%
Valuation
Industry RankSector Rank
PE 18.35
Fwd PE 24.22
P/S 0.26
P/FCF 13.58
P/OCF 3.52
P/B 0.39
P/tB 0.9
EV/EBITDA 6.02
EPS(TTM)0.96
EY5.45%
EPS(NY)0.73
Fwd EY4.13%
FCF(TTM)1.3
FCFY7.36%
OCF(TTM)5
OCFY28.39%
SpS68.19
BVpS45.2
TBVpS19.51
PEG (NY)N/A
PEG (5Y)N/A
Graham Number31.25
Profitability
Industry RankSector Rank
ROA -2.97%
ROE -6.23%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 20.52%
FCFM 1.9%
ROA(3y)1.66%
ROA(5y)3.5%
ROE(3y)3.89%
ROE(5y)9.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-49.18%
OM growth 5Y-37.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.56%
GM growth 5Y-4.64%
F-Score6
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 22.13
Debt/EBITDA 4.55
Cap/Depr 50.71%
Cap/Sales 5.43%
Interest Coverage N/A
Cash Conversion 81.82%
Profit Quality N/A
Current Ratio 2.6
Quick Ratio 1.29
Altman-Z 1.89
F-Score6
WACC4.4%
ROIC/WACCN/A
Cap/Depr(3y)54.6%
Cap/Depr(5y)69.53%
Cap/Sales(3y)4.97%
Cap/Sales(5y)6.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.28%
EPS 3Y-31.1%
EPS 5Y-19.38%
EPS Q2Q%-108.14%
EPS Next Y-76.8%
EPS Next 2Y-32.14%
EPS Next 3Y-2.73%
EPS Next 5Y6.37%
Revenue 1Y (TTM)-6.82%
Revenue growth 3Y1.43%
Revenue growth 5Y-1.32%
Sales Q2Q%-16.27%
Revenue Next Year-9.82%
Revenue Next 2Y-5.41%
Revenue Next 3Y-2.72%
Revenue Next 5Y-0.3%
EBIT growth 1Y82.42%
EBIT growth 3Y-48.45%
EBIT growth 5Y-38.23%
EBIT Next Year1016.78%
EBIT Next 3Y136.04%
EBIT Next 5Y75.06%
FCF growth 1Y-74.13%
FCF growth 3YN/A
FCF growth 5Y6.85%
OCF growth 1Y-44.97%
OCF growth 3Y7.67%
OCF growth 5Y-4.6%

LANXESS AG / LXS.DE FAQ

Can you provide the ChartMill fundamental rating for LANXESS AG?

ChartMill assigns a fundamental rating of 3 / 10 to LXS.DE.


Can you provide the valuation status for LANXESS AG?

ChartMill assigns a valuation rating of 4 / 10 to LANXESS AG (LXS.DE). This can be considered as Fairly Valued.


What is the profitability of LXS stock?

LANXESS AG (LXS.DE) has a profitability rating of 2 / 10.


Can you provide the financial health for LXS stock?

The financial health rating of LANXESS AG (LXS.DE) is 4 / 10.


What is the expected EPS growth for LANXESS AG (LXS.DE) stock?

The Earnings per Share (EPS) of LANXESS AG (LXS.DE) is expected to decline by -76.8% in the next year.